Mpox vaccine approved in Singapore for adults deemed at high risk

Anna Maria Romero
Wed, 28 Aug 2024 10:16:48 +0000
Featured News, Singapore News, HSA, mpox, vaccine

SINGAPORE: A vaccine for mpox from the Danish pharmaceutical company Bavarian Nordic was approved by the Health Sciences Authority (HSA), Singapore’s medicines regulatory authority. JYNNEOS, which is also a smallpox vaccine, has been approved for individuals aged 18 and older who have been deemed at high risk for smallpox or pox infections. The vaccine was …